Exhaled Breath Condensate: Technical and Diagnostic Aspects

Scientific World Journal

Volumn 2015, Issue , 2015, Pages

  Konstantinidi, Efstathia M ^a,b   Lappas, Andreas S ^a,b   Tzortzi, Anna S ^a   Behrakis, Panagiotis K ^a,b  

^a Hellenic Cancer Society Athens   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EXHALED BREATH CONDENSATE; LEUKOTRIENE; POLYPROPYLENE; PROSTAGLANDIN E2; RANTES; UNCLASSIFIED DRUG; VOLATILE AGENT;

ARTIFICIAL VENTILATION; ASTHMA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CYSTIC FIBROSIS; EXPIRATORY FLOW RATE; EXPIRED AIR; FIBROSING ALVEOLITIS; HUMAN; HUMIDITY; LUNG CANCER; LUNG FLUID; MEDICAL DEVICE; MEDLINE; PASSIVE SMOKING; PH; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SCIENCEDIRECT; SLEEP DISORDERED BREATHING; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPERATURE; BREATH ANALYSIS; EXHALATION; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY TRACT DISEASES;

BIOMARKERS; BREATH TESTS; EXHALATION; HUMANS; RESPIRATORY TRACT DISEASES;

EID: 84935921422     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2015/435160     Document Type: Review

References (228)

1. I. Horvath, J. Hunt, P. J. Barnes, et al., "Exhaled breath condensate: methodological recommendations and unresolved questions, " European Respiratory Journal, vol. 26, no. 3, pp. 523-548, 2005.
2. A. S. Jackson, A. Sand rini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates, "Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage, " American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 3, pp. 222-227, 2007.
3. P. Montuschi, D. Paris, D. Melck, et al., "NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis, " Thorax, vol. 67, no. 3, pp. 222-228, 2012.
4. R. Aebersold and M. Mann, "Mass spectrometry-based proteomics, " Nature, vol. 422, no. 6928, pp. 198-207, 2003.
5. J. E. Wiktorowicz and M. Jamaluddin, "Proteomics analysis of the asthmatic airway, " in Heterogeneity in Asthma, vol. 795 of Advances in Experimental Medicine and Biology, pp. 221-232, Springer, NewYork, NY, USA, 2014.
6. P. Xiao, J.-R. Chen, F. Zhouet al., "MethylationofP16 in exhaled breath condensate for diagnosis of non-small cell lung cancer, " Lung Cancer, vol. 83, no. 1, pp. 56-60, 2014.
7. P. M.-L. Sinues, R. Zenobi, and M. Kohler, "Analysis of the exhalome: a diagnostic tool of the future, " Chest, vol. 144, no. 3, pp. 746-749, 2013.
8. M. Hakim, S. Billan, U. Tisch, et al., "Diagnosis of head and neck cancer from exhaled breath, " British Journal of Cancer, vol. 104, no. 10, pp. 1649-1655, 2011.
9. W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Gorski, "Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis, " Chest, vol. 132, no. 2, pp. 589-596, 2007.
10. K. Czebe, I. Barta, B. Antus, M. Valyon, I. Horvath, and T. Kullmann, "Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations, " Respiratory Medicine, vol. 102, no. 5, pp. 720-725, 2008.
11. S. R. Carter, C. S. Davis, and E. J. Kovacs, "Exhaled breath condensate collection in the mechanically ventilated patient, " Respiratory Medicine, vol. 106, no. 5, pp. 601-613, 2012.
12. P. V. Romero, B. Rodrigeuz, S. Martinez, R. Canizares, D. Sepulveda, and F. Manresa, "Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections, " Archivos de Bronconeumologia, vol. 42, no. 3, pp. 113-119, 2006.
13. L. Scheideler, H.-G. Manke, U. Schwulera, O. Inacker, and H. Hammerle, "Detection of nonvolatile macromolecules in breath: a possible diagnostic tool?" American Review of Respiratory Disease, vol. 148, no. 3, pp. 778-784, 1993.
14. J. Vaughan, L. Ngamtrakulpanit, T. N. Pajewski, et al., "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity, " European Respiratory Journal, vol. 22, no. 6, pp. 889-894, 2003.
15. P. Montuschi and P. J. Barnes, "Exhaled leukotrienes and prostagland ins in asthma, " Journal of Allergy and Clinical Immunology, vol. 109, no. 4, pp. 615-620, 2002.
16. C. I. Fairchild and J. F. Stampfer, "Particle concentration in exhaled breath, " American Industrial Hygiene Association Journal, vol. 48, no. 11, pp. 948-949, 1987.
17. J. B. McCafferty, T. A. Bradshaw, S. Tate, A. P. Greening, and J. A. Innes, "Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations, " Thorax, vol. 59, no. 8, pp. 694-698, 2004.
18. J. S. Debley, A. S. Ohanian, C. F. Spiekerman, M. L. Aitken, and T. S. Hallstrand, "Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate, " Chest, vol. 139, no. 1, pp. 16-22, 2011.
19. J. Liu and P. S. Thomas, "Relationship between exhaled breath condensate volume and measurements of lung volumes, " Respiration, vol. 74, no. 2, pp. 142-145, 2007.
20. A. Davidsson, K. N. Sjosward, L. Lundman, and B. Schmekel, "Quantitative assessment and repeatability of chlorine in exhaled breath condensate: comparison of two types of condensators, " Respiration, vol. 72, no. 5, pp. 529-536, 2005.
21. T. Kullmann, I. Barta, B. Antus, M. Valyon, and I. Horvarth, "Environmental temperature and relative humidity influence exhaled breath condensate pH, " European Respiratory Journal, vol. 31, no. 2, pp. 474-475, 2008.
22. M. B. Schleiss, O. Holz, M. Behnke, K. Richter, H. Magnussen, and R. A. Jorres, "The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate, " European Respiratory Journal, vol. 16, no. 6, pp. 1115-1118, 2000.
23. R. W. Hoyt and A. Honig, Body Fluid Balance: Exercise and Sport, CRC Press, Boca Raton, Fla, USA, 1996.
24. R. M. Effros, M. B. Dunning III, J. Biller, and R. Shaker, "The promise and perils of exhaled breath condensates, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 287, no. 6, pp. L1073-L1080, 2004.
25. P. P. R. Rosias, E. Dompeling, H. J. E. Hendriks, J. W. C. M. Heijnens, R. A. M. G. Donckerwolcke, and Q. Jobsis, "Exhaled breath condensate in children: pearls and pitfalls, " Pediatric Allergy and Immunology, vol. 15, no. 1, pp. 4-19, 2004.
26. R. S. Papineni and F. S. Rosenthal, "The size distribution of droplets in the exhaled breath of healthy human subjects, " Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, vol. 10, no. 2, pp. 105-116, 1997.
27. G. R. Johnson and L. Morawska, "The mechanism of breath aerosol formation, " Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 22, no. 3, pp. 229-237, 2009.
28. J. Hunt, "Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease, " Journal of Allergy and Clinical Immunology, vol. 110, no. 1, pp. 28-34, 2002.
29. B. Balbi, P. Pignatti, M. Corradi, et al., "Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults, " European Respiratory Journal, vol. 30, no. 4, pp. 769-781, 2007.
30. R. M. Effros, K. W. Hoagland, M. Boasbous, et al., "Dilution of respiratory solutes in exhaled condensates, "American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 663-669, 2002.
31. P. Rosias, C. Robroeks, J. Hendriks, E. Dompeling, Q. Jobsis, and I. Rahman, "Exhaled breath condensate: a space odessey, where no one has gone before, " European Respiratory Journal, vol. 24, no. 1, pp. 189-190, 2004.
32. I. Cepelak and S. Dodig, "Exhaled breath condensate: a new method for lung disease diagnosis, " Clinical Chemistry and Laboratory Medicine, vol. 45, no. 8, pp. 945-952, 2007.
33. P. Montuschi, "Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications, " Therapeutic Advances in Respiratory Disease, vol. 1, no. 1, pp. 5-23, 2007.
34. R. M. Effros, J. Biller, B. Foss, et al., "Asimplemethod for estimating respiratory solute dilution in exhaled breath condensates, " American Journal of Respiratory and Critical CareMedicine, vol. 168, no. 12, pp. 1500-1505, 2003.
35. T. M. Dwyer, "Sampling airway surface liquid: non-volatiles in the exhaled breath condensate, " Lung, vol. 182, no. 4, pp. 241-250, 2004.
36. C. Gessner, H. Kuhn, H.-J. Seyfarth, et al., "Factors influencing breath condensate volume, " Pneumologie, vol. 55, no. 9, pp. 414-419, 2001.
37. J. T. Zakrzewski, N. C. Barnes, J. F. Costello, and P. J. Piper, "Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease, " American Review of Respiratory Disease, vol. 136, no. 3, pp. 779-782, 1987.
38. E. Huszar, G. Vass, E. Vizi, et al., "Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma, " European Respiratory Journal, vol. 20, no. 6, pp. 1393-1398, 2002.
39. B. Balint, L. E. Donnelly, T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, "Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke, " Thorax, vol. 56, no. 6, pp. 456-461, 2001.
40. P. Montuschi, J. V. Collins, G. Ciabattoni, et al., "Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers, " American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, pp. 1175-1177, 2000.
41. A. L. Calusic, V. M. Varnai, and J. Macan, "Acute effects of smoking and food consumption on breath condensate pH in healthy adults, " Experimental Lung Research, vol. 37, no. 2, pp. 92-100, 2011.
42. T. Kullmann, I. Barta, B. Antus, and I. Horvath, "Drinking influences exhaled breath condensate acidity, " Lung, vol. 186, no. 4, pp. 263-268, 2008.
43. American Thoracic Society, "Recommendations for stand ardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999, " American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2104-2117, 1999.
44. T. Kullman, I. Barta, Z. Lazar, et al., "Exhaled breath condensate pH stand ardised for CO2 partial pressure, " European Respiratory Journal, vol. 29, no. 3, pp. 496-501, 2007.
45. J. C. Ojoo, S. A. Mulrennan, J. A. Kastelik, A. H. Morice, and A. E. Redington, "Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis, " Thorax, vol. 60, no. 1, pp. 22-26, 2005.
46. "ATS Workshop Proceedings: exhaled breath condensate nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate, " Proceedings of the American Thoracic Society, vol. 3, pp. 131-145, 2006.
47. K. Syslova, P. Kacer, B. Vilhanova, et al., "Determination of cysteinyl leukotrienes in exhaled breath condensate: method combining immunoseparation with LC-ESI-MS/MS, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 23, pp. 2220-2228, 2011.
48. J. S. Debley, T. S. Hallstrand, T. Monge, A. Ohanian, G. J. Redding, and J. J. Zimmerman, "Methods to improvemeasurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls, " Journal of Allergy and Clinical Immunology, vol. 120, no. 5, pp. 1216-1217, 2007.
49. J. D. Pleil, H. F. Hubbard, J. R. Sobus, K. Sawyer, and M. C. Madden, "Volatile polar metabolites in exhaled breath condensate (EBC): collection and analysis, " Journal of Breath Research, vol. 2, no. 2, Article ID 026001, 2008.
50. M. Janicka, P. Kubica, A. Kot-Wasik, J. Kot, and J. Namiesnik, "Sensitive determination of isoprostanes in exhaled breath condensate samples with use of liquid chromatography-tand em mass spectrometry, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 893-894, pp. 144-149, 2012.
51. R. M. Effros, R. Casaburi, J. Su, et al., "The effects of volatile salivary acids and bases on exhaled breath condensate pH, " The American Journal of Respiratory and Critical CareMedicine, vol. 173, no. 4, pp. 386-392, 2006.
52. C. Gessner, R. Scheibe, M. Wotzel, et al., "Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease, " Respiratory Medicine, vol. 99, no. 10, pp. 1229-1240, 2005.
53. P. P. Rosias, "Methodological aspects of exhaled breath condensate collection and analysis, " Journal of Breath Research, vol. 6, no. 2, Article ID 027102, 2012.
54. Z. Vlasic, S. Dodig, I. Cepelak, et al., "Iron and ferritin concentrations in exhaled breath condensate of children with asthma, " Journal of Asthma, vol. 46, no. 1, pp. 81-85, 2009.
55. R. M. Effros, B. Peterson, R. Casaburi, et al., "Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects, " Journal of AppliedPhysiology, vol. 99, no. 4, pp. 1286-1292, 2005.
56. P. Montuschi, New Perspectives in Monitoring Lung Inflammation. Analysis of Exhaled Breath Condensate, CRC Press, Boca Raton, Fla, USA, 2005.
57. G. I. Sidorenko, E. I. Zborovski, and D. I. Levina, "Surfaceactive properties of the exhaled air condensate (a new method of studying lung function), " Terapevticheskii Arkhiv, vol. 52, no. 3, pp. 65-68, 1980.
58. M. Janicka, A. Kot-Wasik, J. Kot, and J. Namiesnik, "Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis, " International Journal of Molecular Sciences, vol. 11, no. 11, pp. 4631-4659, 2010.
59. E. Glowacka, U. Jedynak-Wasowicz, M. Sanak, and G. Lis, "Exhaled eicosanoid profiles in children with atopic asthma and healthy controls, " Pediatric Pulmonology, vol. 48, no. 4, pp. 324-335, 2013.
60. M. A. Molina, W. Zhao, S. Sankaran, M. Schivo, N. J. Kenyon, and C. E. Davis, "Design-of-experiment optimization of exhaled breath condensate analysis using a miniature differential mobility spectrometer (DMS), " Analytica Chimica Acta, vol. 628, no. 2, pp. 155-161, 2008.
61. C. E. Davis, M. J. Bogan, S. Sankaran, et al., "Analysis of volatile and non-volatile biomarkers in human breath using differential mobility spectrometry (DMS), " IEEE Sensors Journal, vol. 10, no. 1, pp. 114-122, 2010.
62. L. Brunetti, R. Francavilla, R. Tesse, et al., "Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis, " Pediatric Allergy and Immunology, vol. 17, no. 6, pp. 422-427, 2006.
63. A. Niimi, L. T. Nguyen, O. Usmani, B. Mann, and K. F. Chung, "Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough, " Thorax, vol. 59, no. 7, pp. 608-612, 2004.
64. G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov, "Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?" Chest, vol. 125, no. 6, pp. 2005-2010, 2004.
65. P. P. R. Rosias, E. Dompeling, M. A. Dentener, et al., "Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests, " Pediatric Pulmonology, vol. 38, no. 2, pp. 107-114, 2004.
66. B. Antus, I. Barta, T. Kullmann, et al., "Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study, " American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1492-1497, 2010.
67. K. Kostikas, A. I. Papaioannou, K. Tanou, et al., "Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control, " RespiratoryMedicine, vol. 105, no. 4, pp. 526-532, 2011.
68. J. F. Hunt, K. Fang, R. Malik, et al., "Endogenous airway acidification. Implications for asthma pathophysiology, " American Journal of Respiratory and Critical CareMedicine, vol. 161, no. 3, pp. 694-699, 2000.
69. K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, and S. Loukides, "pH in expired breath condensate of patients with inflammatory airway diseases, " American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 10, pp. 1364-1370, 2002.
70. L. Brunetti, R. Francavilla, R. Tesse, et al., "Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis, " Allergy and Asthma Proceedings, vol. 29, no. 5, pp. 461-467, 2008.
71. N. C. Nicolaou, L. A. Lowe, C. S. Murray, A. Woodcock, A. Simpson, and A. Custovic, "Exhaled breath condensate pH and childhood asthma: unselected birth cohort study, " American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 3, pp. 254-259, 2006.
72. R. Koczulla, S. Dragonieri, R. Schot, et al., "Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients, " Respiratory Research, vol. 10, article 78, 2009.
73. G. MacGregor, S. Ellis, J. Andrews, et al., "Breath condensate ammoniumis lower in childrenwith chronic asthma, " European Respiratory Journal, vol. 26, no. 2, pp. 271-276, 2005.
74. A. Antczak, D. Nowak, B. Shariati, M. Krol, G. Piasecka, and Z. Kurmanowska, "Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients, " European Respiratory Journal, vol. 10, no. 6, pp. 1235-1241, 1997.
75. Y. Teng, P. Sun, J. Zhang, et al., "Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker?" Chest, vol. 140, no. 1, pp. 108-116, 2011.
76. B. Samuelsson, "Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation, " Science, vol. 220, no. 4597, pp. 568-575, 1983.
77. E. Ono, H. Mita, M. Taniguchi, et al., "Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation, " The Journal of Allergy and Clinical Immunology, vol. 122, no. 4, pp. 768. e1-773. e1, 2008.
78. S. Carraro, M. Corradi, S. Zanconato, et al., "Exhaled breath condensate cysteinyl leukotrienes are increased in childrenwith exercise-induced bronchoconstriction, " The Journal of Allergy and Clinical Immunology, vol. 115, no. 4, pp. 764-770, 2005.
79. A. Bikov, R. Gajdocsi, E. Huszar, et al., "Exercise increases exhaled breath condensate cysteinyl leukotriene concentration in asthmatic patients, " Journal of Asthma, vol. 47, no. 9, pp. 1057-1062, 2010.
80. S. T. Holgate, M. Peters-Golden, R. A. Panettieri, et al., "Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling, "The Journal of Allergy and Clinical Immunology, vol. 111, no. 1, pp. S18-S36, 2003.
81. A. Antczak, P. Montuschi, S. Kharitonov, P. Gorski, and P. J. Barnes, "Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma, " American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 3, pp. 301-306, 2002.
82. Z. Csoma, S. A. Kharitonov, B. Balint, A. Bush, N. M. Wilson, and P. J. Barnes, "Increased leukotrienes in exhaled breath condensate in childhood asthma, " American Journal of Respiratory and Critical CareMedicine, vol. 166, no. 10, pp. 1345-1349, 2002.
83. C. Mondino, G. Ciabattoni, P. Koch, et al., "Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children, "The Journal of Allergy and Clinical Immunology, vol. 114, no. 4, pp. 761-767, 2004.
84. P. Cap, J. Chladek, F. Pehal, et al., "Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients, " Thorax, vol. 59, no. 6, pp. 465-470, 2004.
85. S. Zanconato, S. Carraro, M. Corradi, et al., "Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma, "The Journal of Allergy and Clinical Immunology, vol. 113, no. 2, pp. 257-263, 2004.
86. P. Montuschi, C. Mondino, P. Koch, P. J. Barnes, and G. Ciabattoni, "Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma, " The Journal of Allergy and Clinical Immunology, vol. 118, no. 2, pp. 347-353, 2006.
87. A. Shibata, T. Katsunuma, M. Tomikawa, et al., "Increased leukotriene E4 in the exhaled breath condensate of children with mild asthama, " Chest, vol. 130, no. 6, pp. 1718-1722, 2006.
88. B. Kielbasa, A. Moeller, M. Sanak, et al., "Eicosanoids in exhaled breath condensates in the assessment of childhood asthma, " Pediatric Allergy and Immunology, vol. 19, no. 7, pp. 660-669, 2008.
89. T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, "Increased nitrotyrosine in exhaled breath condensate of patients with asthma, " American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1273-1276, 2000.
90. E. Baraldi, S. Carraro, R. Alinovi, et al., "Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of childrenwith asthma exacerbations, " Thorax, vol. 58, no. 6, pp. 505-509, 2003.
91. P. Montuschi, S. A. Kharitonov, G. Ciabattoni, and P. J. Barnes, "Exhaled leukotrienes and prostagland ins in COPD, " Thorax, vol. 58, no. 7, pp. 585-588, 2003.
92. A. Bodini, C. DOrazio, D. Peroni, et al., "Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections, " Pediatric Pulmonology, vol. 40, no. 6, pp. 494-499, 2005.
93. G. E. Carpagnano, G. P. Palladino, D. Lacedonia, A. Koutelou, S. Orland o, and M. P. Foschino-Barbaro, "Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8, " BMC Cancer, vol. 11, article 226, 2011.
94. P. Montuschi, M. Corradi, G. Ciabattoni, J. Nightingale, S. A. Kharitonov, and P. J. Barnes, "Increased 8-isoprostane, amarker of oxidative stress, in exhaled condensate of asthma patients, " American Journal of Respiratory and Critical CareMedicine, vol. 160, no. 1, pp. 216-220, 1999.
95. E. Baraldi, L. Ghiro, V. Piovan, et al., "Increased exhaled 8-isoprostane in childhood asthma, " Chest, vol. 124, no. 1, pp. 25-31, 2003.
96. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides, "Prostagland in E2 in the expired breath condensate of patients with asthma, " European Respiratory Journal, vol. 22, no. 5, pp. 743-747, 2003.
97. S. K. Shahid, S. A. Kharitonov, N. M. Wilson, A. Bush, and P. J. Barnes, "Increased interleukin-4 and decreased interferon-β in exhaled breath condensate of children with asthma, " American Journal of Respiratory and Critical CareMedicine, vol. 165, no. 9, pp. 1290-1293, 2002.
98. G. E. Carpagnano, O. Resta, M. Gelardi, et al., "Exhaled inflammatory markers in aspirin-induced asthma syndrome, " American Journal of Rhinology, vol. 21, no. 5, pp. 542-547, 2007.
99. G. E. Carpagnano, O. Resta, M. T. Ventura, et al., "Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma, " Journal of Internal Medicine, vol. 259, no. 3, pp. 323-331, 2006.
100. G. E. Carpagnano, M. P. Foschino Barbaro, O. Resta, et al., "Exhaled markers in the monitoring of airways inflammation and its response to steroids treatment in mild persistent asthma, " European Journal of Pharmacology, vol. 519, no. 1-2, pp. 175-181, 2005.
101. C. M. H. H. T. Robroeks, K. D. G. van de Kant, Q. Jobsis, et al., "Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma, " Clinical&Experimental Allergy, vol. 37, no. 9, pp. 1303-1311, 2007.
102. T.-F. Leung, G. W. K. Wong, F. W. S. Ko, et al., "Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children, " International Archives of Allergy and Immunology, vol. 137, no. 1, pp. 66-72, 2005.
103. M. Profita, S. La Grutta, E. Carpagnano, et al., "Noninvasive methods for the detection of upper and lower airway inflammation in atopic children, "The Journal of Allergy and Clinical Immunology, vol. 118, no. 5, pp. 1068-1074, 2006.
104. G. E. Carpagnano, M. P. F. Barbaro, M. Cagnazzo, et al., "Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge, " Chest, vol. 128, no. 5, pp. 3159-3166, 2005.
105. K. Matsunaga, S. Yanagisawa, T. Ichikawa, et al., "Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients, "The Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 84-90, 2006.
106. K. F. Chung and P. J. Barnes, "Cytokines in asthma, " Thorax, vol. 54, no. 9, pp. 825-857, 1999.
107. Z. Zietkowski, R. Skiepko, M. M. Tomasiak, and A. Bodzenta-Lukaszyk, "Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients, " Respiratory Medicine, vol. 102, no. 3, pp. 470-474, 2008.
108. Z. Zietkowski, M. M. Tomasiak, R. Skiepko, and A. Bodzenta-Lukaszyk, "RANTES in exhaled breath condensate of stable and unstable asthma patients, " Respiratory Medicine, vol. 102, no. 8, pp. 1198-1202, 2008.
109. K. Bloemen, R. van den Heuvel, E. Govarts, et al., "A new approach to study exhaled proteins as potential biomarkers for asthma, " Clinical & Experimental Allergy, vol. 41, no. 3, pp. 346-356, 2011.
110. M. I. Bartoli, F. Novelli, F. Costa, et al., "Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases, " Mediators of Inflammation, vol. 2011, Article ID 891752, 7 pages, 2011.
111. S. Carraro, G. Giordano, G. Piacentini, et al., "Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma, " Chest, vol. 144, no. 2, pp. 405-410, 2013.
112. Z. Zietkowski, M. M. Tomasiak-Lozowska, R. Skiepko, E. Zietkowska, and A. Bodzenta-Lukaszyk, "Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients, " Respiratory Research, vol. 11, article 110, 2010.
113. Z. Zietkowski, R. Skiepko, M. M. Tomasiak-Lozowska, and A. Bodzenta-Lukaszyk, "Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy, " Advances in Medical Sciences, vol. 56, no. 2, pp. 318-322, 2011.
114. Z. Zietkowski, M. M. Tomasiak-Lozowska, R. Skiepko, B. Mroczko, M. Szmitkowski, and A. Bodzenta-Lukaszyk, "Highsensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma, " RespiratoryMedicine, vol. 103, no. 3, pp. 379-385, 2009.
115. E. M. Klaassen, K. D. van de Kant, Q. Jobsis, et al., "Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma, " Pediatric Allergy and Immunology, vol. 25, no. 2, pp. 166-172, 2014.
116. L. Liu, W. G. Teague, S. Erzurumet al., "Determinants of exhaled breath condensate pHin a large population with asthma, " Chest, vol. 139, no. 2, pp. 328-336, 2011.
117. S. Banovic, M. Navratil, Z. Vlasic, R. Z. Topic, and S. Dodig, "Calcium and magnesium in exhaled breath condensate of children with endogenous and exogenous airway acidification, " Journal of Asthma, vol. 48, no. 7, pp. 667-673, 2011.
118. A. M. Fitzpatrick, J. T. Holbrook, C. Y. Wei, M. S. Brown, R. A. Wise, and W. G. Teague, "Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma, "The Journal of Allergy and Clinical Immunology, vol. 2, no. 5, pp. 579. e7-586. e7, 2014.
119. Y. Shimizu, K. Dobashi, J. J. Zhao, et al., "Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease, " Respiration, vol. 74, no. 5, pp. 558-564, 2007.
120. T. Soyer, O. U. Soyer, E. Birben, U. Kisa, O. Kalayci, and M. Cakmak, "Pepsin levels and oxidative stress markers in exhaled breath condensate of patients with gastroesophageal reflux disease, " Journal of Pediatric Surgery, vol. 48, no. 11, pp. 2247-2250, 2013.
121. A. I. Papaioannou, A. Koutsokera, K. Tanou, et al., "The acute effect of smoking in healthy and asthmatic smokers, " European Journal of Clinical Investigation, vol. 40, no. 2, pp. 103-109, 2010.
122. A.-R. Koczulla, S. Noeske, C. Herr, et al., "Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers, " Respiration, vol. 79, no. 1, pp. 61-67, 2010.
123. K. Tanou, A. Koutsokera, T. S. Kiropoulos, et al., "Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking, " Clinical & Experimental Allergy, vol. 39, no. 3, pp. 345-353, 2009.
124. B. Kane, Z. Borrill, T. Southworth, A. Woodcock, and D. Singh, "Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroids, " Respirology, vol. 14, no. 3, pp. 419-423, 2009.
125. L. Bentur, E. Hellou, A. Goldbart, et al., "Laboratory and clinical acute effects of active and passive indoor group water-pipe (Narghile) smoking, " Chest, vol. 145, no. 4, pp. 803-809, 2014.
126. M. L. Nicola, H. B. de Carvalho, C. T. Yoshida, et al., "Young healthy smokers have functional and inflammatory changes in the nasal and the lower airways, " Chest, vol. 145, no. 5, pp. 998-1005, 2014.
127. G. E. Carpagnano, S. A. Kharitonov, M. P. Foschino-Barbaro, O. Resta, E. Gramiccioni, and P. J. Barnes, "Increase inflammatory markers in the exhaled breath condensate of cigarette smokers, " European Respiratory Journal, vol. 21, no. 4, pp. 589-593, 2003.
128. W. Mazur, H. Stark, A. Sovijarvi, M. Myllarniemi, and V. L. Kinnula, "Comparison of 8-isoprostane and interleukin in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers, " Respiration, vol. 78, no. 2, pp. 209-216, 2009.
129. J. M. Diez-Pina, M. J. Fernand ez-Acenero, M. J. Llorente-Alonso, S. Diaz-Lobato, S. Mayoralas, and A. Florez, "Tumor necrosis factor alpha as a marker of systemic and local inflammation in healthy smokers, " International Journal of General Medicine, vol. 2, pp. 9-14, 2009.
130. D. Celik, S. Doruk, H. I. Koseoglu, S. Sahin, S. Celikel, and U. Erkorkmaz, "Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics, " Clinical Chemistry and Laboratory Medicine, vol. 51, no. 5, pp. 1069-1073, 2013.
131. K. Kostikas, M. Minas, E. Nikolaou, et al., "Secondhand smoke exposure induces acutely airway acidification and oxidative stress, " Respiratory Medicine, vol. 107, no. 2, pp. 172-179, 2013.
132. Z. Borrill, C. Starkey, J. Vestbo, and D. Singh, "Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease, " European Respiratory Journal, vol. 25, no. 2, pp. 269-274, 2005.
133. W. MacNee, S. I. Rennard, J. F. Hunt, et al., "Evaluation of exhaled breath condensate pH as a biomarker for COPD, " Respiratory Medicine, vol. 105, no. 7, pp. 1037-1045, 2011.
134. A. I. Papaioannou, S. Loukides, M. Minas, et al., "Exhaled breath condensatepHas a biomarker ofCOPDseverity in ex-smokers, " Respiratory Research, vol. 12, article 67, 2011.
135. P. N. R. Dekhuijzen, K. K. H. Aben, I. Dekker, et al., "Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease, " The American Journal of Respiratory and Critical CareMedicine, vol. 154, no. 3, pp. 813-816, 1996.
136. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides, "Oxidative stress in expired breath condensate of patients with COPD, " Chest, vol. 124, no. 4, pp. 1373-1380, 2003.
137. D. Nowak, M. Kasielski, A. Antczak, T. Pietras, and P. Bialasiewicz, "Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking, " Respiratory Medicine, vol. 93, no. 6, pp. 389-396, 1999.
138. M. Corradi, I. Rubinstein, R. Andreoli, et al., "Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease, " The American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 10, pp. 1380-1386, 2003.
139. M. Corradi, P. Pignatti, P. Manini, et al., "Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation, " European Respiratory Journal, vol. 24, no. 6, pp. 1011-1017, 2004.
140. B. Antus, G. Harnasi, O. Drozdovszky, and I. Barta, "Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde, " Respirology, vol. 19, no. 1, pp. 74-79, 2014.
141. K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides, "Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma, " Chest, vol. 127, no. 5, pp. 1553-1559, 2005.
142. J. L. Izquierdo, C. Almonacid, T. Parra, and J. Perez, "Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease, " Archivos de Bronconeumologia, vol. 42, no. 7, pp. 332-337, 2006.
143. Z. L. Borrill, R. C. Starkey, and S. D. Singh, "Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 71-76, 2007.
144. M. Fumagalli, F. Ferrari, M. Luisetti, et al., "Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS, " International Journal of Molecular Sciences, vol. 13, no. 11, pp. 13894-13910, 2012.
145. G. Warwick, P. S. Thomas, and D. H. Yates, "Non-invasive biomarkers in exacerbations of obstructive lung disease, " Respirology, vol. 18, no. 5, pp. 874-884, 2013.
146. A. Antczak, M. Ciebiada, T. Pietras, W. J. Piotrowski, Z. Kurmanowska, and P. Gorski, "Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease, " Archives of Medical Science, vol. 8, no. 2, pp. 277-285, 2012.
147. W. A. Biernacki, S. A. Kharitonov, and P. J. Barnes, "Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD, " Thorax, vol. 58, no. 4, pp. 294-298, 2003.
148. G. E. Carpagnano, O. Resta, M. P. Foschino-Barbaro, et al., "Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys), " European Journal of Pharmacology, vol. 505, no. 1-3, pp. 169-175, 2004.
149. V. Rihak, P. Zatloukal, J. Chladkova, A. Zimulova, Z. Havlinova, and J. Chladek, "Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis, " Journal of Clinical Laboratory Analysis, vol. 24, no. 5, pp. 317-322, 2010.
150. A. R. Koczulla, S. Noeske, C. Herr, et al., "Alpha-1 antitrypsin is elevated in exhaled breath condensate and serumin exacerbated COPD patients, " Respiratory Medicine, vol. 106, no. 1, pp. 120-126, 2012.
151. S. Kwiatkowska, K. Noweta, M. Zieba, D. Nowak, and P. Bialasiewicz, "Enhanced exhalation of matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study, " Respiration, vol. 84, no. 3, pp. 231-241, 2012.
152. J. L. Corhay, C. Moermans, M. Henket, D. N. Dang, B. Duysinx, and R. Louis, "Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD, " Respiratory Research, vol. 15, no. 1, pp. 115-126, 2014.
153. N. Kubysheva, S. Soodaeva, L. Postnikova, V. Novikov, A. Maksimova, and A. Chuchalin, "Associations between indicators of nitrosative stress and levels of soluble HLA-I, CD95 molecules in patients with COPD, " Journal of Chronic Obstructive Pulmonary Disease, vol. 11, no. 6, pp. 639-644, 2014.
154. N. L. Tateosian, M. J. Costa, D. Guerrieri, A. Barro, J. A. Mazzei, and H. E. Chuluyan, "Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients, " Cytokine, vol. 58, no. 3, pp. 361-367, 2012.
155. T. Zakharkina, A.-R. Koczulla, O. Mardanova, A. Hattesohl, and R. Bals, "Detection of microorganisms in exhaled breath condensate during acute exacerbations of COPD, " Respirology, vol. 16, no. 6, pp. 932-938, 2011.
156. E. C. Lases, V. A. M. Duurkens, W. B. M. Gerritsen, and F. J. L. M. Hass, "Oxidative stress after lung resection therapy, " Chest, vol. 117, pp. 99-103, 2000.
157. G. E. Carpagnano, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and F. Carpagnano, "Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer, " International Journal of BiologicalMarkers, vol. 17, no. 2, pp. 141-145, 2002.
158. G. E. Carpagnano, A. Spanevello, C. Curci, et al., "IL-2, TNF-κ, and leptin: local versus systemic concentrations in NSCLC patients, " Oncology Research, vol. 16, no. 8, pp. 375-381, 2007.
159. L. Brussino, B. Culla, C. Bucca, et al., "Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer, " Journal of Breath Research, vol. 8, no. 2, Article ID 027110, 2014.
160. G. E. Carpagnano, M. P. Foschino-Barbaro, O. Restaa, E. Gramiccioni, and F. Carpagnano, "Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer, " Oncology, vol. 66, no. 3, pp. 180-184, 2004.
161. E. Dalaveris, T. Kerenidi, A. Katsabeki-Katsafli, et al., "VEGF, TNF-κ and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer, " Lung Cancer, vol. 64, no. 2, pp. 219-225, 2009.
162. T. Kullmann, I. Barta, E. Csiszer, B. Antus, and I. Horvath, "Differential cytokine pattern in the exhaled breath of patients with lung cancer, " Pathology and Oncology Research, vol. 14, no. 4, pp. 481-483, 2008.
163. I. Barta, T. Kullmann, E. Csiszer, and B. Antus, "Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma, " International Journal of Biological Markers, vol. 25, no. 1, pp. 52-56, 2010.
164. W. Jungraithmayr, C. Frings, G. Zissel, A. Prasse, B. Passlick, and E. Stoelben, "Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma, " Respirology, vol. 13, no. 7, pp. 1022-1027, 2008.
165. C. Gessner, B. Rechner, S. Hammerschmidt, et al., "Angiogenic markers in breath condensate identify non-small cell lung cancer, " Lung Cancer, vol. 68, no. 2, pp. 177-184, 2010.
166. G. E. Carpagnano, A. Spanevello, G. P. Palladino, et al., "Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?" Lung Cancer, vol. 67, no. 1, pp. 108-113, 2010.
167. G. E. Carpagnano, G. P. Palladino, D. Martinelli, D. Lacedonia, S. Orland o, and M. P. Foschino-Barbaro, "Exhaled matrix metalloproteinase-9 in lung cancer, " Rejuvenation Research, vol. 15, no. 4, pp. 359-365, 2012.
168. Z. Cheng, A. K. Chan, C. R. Lewis, P. S. Thomas, and M. J. Raftery, "Comparative proteomics analysis of exhaled breath condensate in lung cancer patients, " Journal of CancerTherapy, vol. 2, no. 1, pp. 1-8, 2011.
169. Y. Zou, L. Wang, C. Zhao, et al., "CEA, SCC and NSE levels in exhaled breath condensate-possible markers for early detection of lung cancer, " Journal of Breath Research, vol. 7, no. 4, Article ID 047101, 2013.
170. C. Gessner, H. Kuhn, K. Toepfer, S. Hammerschmidt, J. Schauer, and H. Wirtz, "Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients, " Lung Cancer, vol. 43, no. 2, pp. 215-222, 2004.
171. G. E. Carpagnano, M. P. Foschino-Barbaro, G. Mule, et al., "3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer, " American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 6, pp. 738-744, 2005.
172. G. E. Carpagnano, M. P. Foschino-Barbaro, A. Spanevello, et al., "3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer, " American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 3, pp. 337-341, 2008.
173. G. E. Carpagnano, A. Spanevello, F. Carpagnano, et al., "Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients, " Lung Cancer, vol. 64, no. 3, pp. 334-340, 2009.
174. G. E. Carpagnano, G. P. Palladino, C. Gramiccioni, M. P. Foschino Barbaro, and D. Martinelli, "Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients, " Lung Cancer, vol. 68, no. 2, pp. 305-307, 2010.
175. P. Mozzoni, I. Band a, M. Goldoni, et al., "Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer, " Biomarkers, vol. 18, no. 8, pp. 679-686, 2013.
176. J. Kordiak, J. Szemraj, K. Hamara, P. Bialasiewicz, and D. Nowak, "Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene, " Respiratory Medicine, vol. 106, no. 9, pp. 1293-1300, 2012.
177. W. Han, T. Wang, A. A. Reilly, S. M. Keller, and S. D. Spivack, "Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients, " Respiratory Research, vol. 10, article 86, 2009.
178. G. E. Carpagnano, A. Koutelou, M. I. Natalicchio, et al., "HPV in exhaled breath condensate of lung cancer patients, " British Journal of Cancer, vol. 105, no. 8, pp. 1183-1190, 2011.
179. G. E. Carpagnano, D. Lacedonia, G. P. Palladino, et al., "Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy, " BMC Pulmonary Medicine, vol. 14, no. 1, article 22, 2014.
180. C. Gessner, S. Hammerschmidt, H. Kuhn, et al., "Exhaled breath condensate acidification in acute lung injury, " Respiratory Medicine, vol. 97, no. 11, pp. 1188-1194, 2003.
181. B. K. Walsh, D. J. Mackey, T. Pajewski, Y. Yu, B. M. Gaston, and J. F. Hunt, "Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients, " Respiratory Care, vol. 51, no. 10, pp. 1125-1131, 2006.
182. O. Roca, S. Gomez-Olles, M.-J. Cruz, X. Munoz, M. J. D. Griffiths, and J. R. Masclans, "Mechanical ventilation induces changes in exhaled breath condensate of patients without lung injury, " Respiratory Medicine, vol. 104, no. 6, pp. 822-828, 2010.
183. I. Korovesi, E. Papadomichelakis, S. E. Orfanos, et al., "Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis, " Anesthesiology, vol. 114, no. 5, pp. 1118-1129, 2011.
184. P. Montushi, "Isoprostanes, prostanoids and leukotrienes in exhaled breath condensate, " in New Prespectives in Monitoring Lung Inflammation. Analysis of Exhaled Breath Condensate, P. Montushi, Ed., pp. 53-66, CRC Press, Boca Raton, Fla, USA, 2005.
185. O. Roca, S. Gomez-Olles, M.-J. Cruz, X. Munoz, M. J. D. Griffiths, and J. R. Masclans, "Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis, " Critical Care, vol. 12, no. 3, article R72, 2008.
186. L. J. Nannini, R. Quintana, D. H. Bagilet, et al., "Exhaled breath condensate pH in mechanically ventilated patients, " Medicina Intensiva, vol. 37, no. 9, pp. 593-599, 2013.
187. C. T. Carpenter, P. V. Price, and B. W. Christman, "Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS, " Chest, vol. 114, no. 6, pp. 1653-1659, 1998.
188. S. R. Baldwin, R. H. Simon, C. M. Grum, L. H. Ketai, L. A. Boxer, and L. J. Devall, "Oxidant activity in expired breath of patients with adult respiratory distress syndrome, " The Lancet, vol. 1, no. 8471, pp. 11-14, 1986.
189. U. Sack, R. Scheibe, M. Wotzel, et al., "Multiplex analysis of cytokines in exhaled breath condensate, " Cytometry Part A, vol. 69, no. 3, pp. 169-172, 2006.
190. E. D. Moloney, S. E. Mumby, R. Gajdocsi, et al., "Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery, " American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 64-69, 2004.
191. C. Gessner, S. Hammerschmidt, H. Kuhn, et al., "Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury, " Chest, vol. 124, no. 3, pp. 1046-1052, 2003.
192. C. Gessner, H. Dihazi, S. Brettschneider, et al., "Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients, " Respiratory Medicine, vol. 102, no. 2, pp. 299-306, 2008.
193. G. Horonenko, J. C. Hoyt, R. A. Robbins, et al., "Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report, " Chest, vol. 132, no. 1, pp. 58-63, 2007.
194. S. Chow, P. S. Thomas, M. Malouf, and D. H. Yates, "Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis, " Journal of Breath Research, vol. 6, no. 1, Article ID 016004, 2012.
195. S. B. Montesi, S. K. Mathai, L. N. Brenner, et al., "Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis, " BMC Pulmonary Medicine, vol. 14, no. 1, article 5, 2014.
196. S. Tate, G. MacGregor, M. Davis, J. A. Innes, and A. P. Greening, "Airways in cystic fibrosis are acidified: detection by exhaled breath condensate, " Thorax, vol. 57, no. 11, pp. 926-929, 2002.
197. B. Antus, I. Barta, E. Csiszer, and K. Kelemen, "Exhaled breath condensate pH in patients with cystic fibrosis, " Inflammation Research, vol. 61, no. 10, pp. 1141-1147, 2012.
198. B. Balint, S. A. Kharitonov, T. Hanazawa, et al., "Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis, " European Respiratory Journal, vol. 17, no. 6, pp. 1201-1207, 2001.
199. S. Celio, H. Troxler, S. S. Durka, et al., "Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma, " Nitric Oxide, vol. 15, no. 3, pp. 226-232, 2006.
200. F. Horak Jr., A. Moeller, F. Singer, et al., "Longitudinal monitoring of pediatric cystic fibrosis lung disease using nitrite in exhaled breath condensate, " Pediatric Pulmonology, vol. 42, no. 12, pp. 1198-1206, 2007.
201. C. M. H. H. T. Robroeks, P. P. R. Rosias, D. van Vliet, et al., "Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children, " Pediatric Allergy and Immunology, vol. 19, no. 7, pp. 652-659, 2008.
202. S. Cunningham, J. R. McColm, L. P. Ho, A. P. Greening, and T. G. Marshall, "Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis, " European Respiratory Journal, vol. 15, no. 5, pp. 955-957, 2000.
203. G. E. Carpagnano, P. J. Barnes, D. M. Geddes, M. E. Hodson, and S. A. Kharitonov, "Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis, " American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 8, pp. 1109-1112, 2003.
204. A. Bodini, C. DOrazio, D. G. Peroni, et al., "IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children, " International Journal of Immunopathology and Pharmacology, vol. 20, no. 3, pp. 467-472, 2007.
205. C. M. H. H. T. Robroeks, Q. Jobsis, J. G. M. C. Damoiseaux, et al., "Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis, " Annals of Allergy, Asthma and Immunology, vol. 96, no. 2, pp. 349-355, 2006.
206. G. Warwick, E. Kotlyar, S. Chow, P. S. Thomas, and D. H. Yates, "Exhaled breath condensate in pulmonary arterial hypertension, " Journal of Breath Research, vol. 6, no. 3, Article ID036006, 2012.
207. H. He, Y. Tao, X. Chen, et al., "High levels of interleukin-6 and 8-iso-prostagland in in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension, " ChineseMedical Journal, vol. 127, no. 9, pp. 1608-1612, 2014.
208. P. Carratu, C. Scoditti, M. Maniscalco, et al., "Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension, " BMC Pulmonary Medicine, vol. 8, article 20, 2008.
209. J. K. Mansoor, E. S. Schelegle, C. E. Davis, et al., "Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension, " PLoS ONE, vol. 9, no. 4, Article IDe95331, 2014.
210. H. Ahmadzai, B. Cameron, J. Chui, A. Lloyd, D. Wakefield, and P. S. Thomas, "Measurement of neopterin, TGF-β and ACE in the exhaled breath condensate of patients with sarcoidosis, " Journal of Breath Research, vol. 7, no. 4, Article ID 046003, 2013.
211. M. A. Biltagi, M. A. Maguid, M. A. Ghafar, and E. Farid, "Correlation of 8-isoprostane, interleukin-6 and cardiac functions with clinical score in childhood obstructive sleep apnoea, " Acta Paediatrica, vol. 97, no. 10, pp. 1397-1405, 2008.
212. A. D. Goldbart, J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal, "Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome, " Chest, vol. 130, no. 1, pp. 143-148, 2006.
213. G. Malakasioti, E. Alexopoulos, C. Befani, et al., "Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA, " Sleep and Breathing, vol. 16, no. 3, pp. 703-708, 2012.
214. V. Vlasic, J. Trifunovic, I. Cepelak, P. Nimac, R. Z. Topic, and S. Dodig, "Urates in exhaled breath condensate of children with obstructive sleep apnea, " Biochemia Medica, vol. 21, no. 2, pp. 139-144, 2011.
215. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, "8-isoprostane in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy, " Chest, vol. 124, no. 4, pp. 1386-1392, 2003.
216. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, "Increased 8-isoprostane and interleukin-6 in breath condensate ofobstructive sleep apnea patients, " Chest, vol. 122, no. 4, pp. 1162-1167, 2002.
217. S. Antonopoulou, S. Loukides, G. Papatheodorou, C. Roussos, and M. Alchanatis, "Airway inflammation in obstructive sleep apnea: is leptin themissing link?" RespiratoryMedicine, vol. 102, no. 10, pp. 1399-1405, 2008.
218. M. Westhoff and P. Litterst, "Obstructive sleep apnoea and oxidative stress, " Pneumologie, vol. 66, no. 10, pp. 610-615, 2012.
219. G. E. Carpagnano, A. Spanevello, R. Sabato, et al., "Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8, " Translational Research, vol. 155, no. 1, pp. 35-43, 2010.
220. A. Nielepkowicz-Gozdzinska, W. Fendler, E. Robak, et al., "Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis, " Archivum Immunologiae et Therapiae Experimentalis, vol. 62, no. 3, pp. 231-238, 2014.
221. A. Nielepkowicz-Gozdzinska, W. Fendler, E. Robak, et al., "Exhaled cytokines in systemic lupus erythematosus with lung involvement, " Polskie Archiwum Medycyny Wewnetrznej, vol. 123, no. 4, pp. 141-148, 2013.
222. G. Rolla, M. Bruno, L. Bommarito, et al., "Breath analysis in patients with end-stage renal disease: effect of haemodialysis, " European Journal of Clinical Investigation, vol. 38, no. 10, pp. 728-733, 2008.
223. J. Rysz, M. Kasielski, J. Apanasiewicz, et al., "Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis, " Nephrology Dialysis Transplantation, vol. 19, no. 1, pp. 158-163, 2004.
224. C. R. E. Esther, R. C. Boucher, M. R. Johnson, et al., "Airway drug pharmacokinetics via analysis of exhaled breath condensate, " Pulmonary Pharmacology & Therapeutics, vol. 27, no. 1, pp. 76-82, 2014.
225. O. Beck, S. Sand qvist, P. Eriksen, J. Franck, and G. Palmskog, "Determination of methadone in exhaled breath condensate by liquid chromatography-tand em mass spectrometry, " Journal of Analytical Toxicology, vol. 35, no. 3, pp. 129-133, 2011.
226. Hippocrates, The Corpus; The Hippocratic Writings, Kaplan Publishing, New York, NY, USA, 2008.
227. P. Montuschi, N. Mores, A. Trove, C. Mondino, and P. J. Barnes, "The electronic nose in respiratory medicine, " Respiration, vol. 85, no. 1, pp. 72-84, 2013.
228. A. Koutsokera, S. Loukides, K. I. Gourgoulianis, and K. Kostikas, "Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values, " Current Medicinal Chemistry, vol. 15, no. 6, pp. 620-630, 2008.